Kikusui Chemical Industries Co., Ltd. (7953.T)
JPY 379.0
(0.0%)
JPY 379.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 1.08 Billion | 500.64 Million | 1.19 Billion | 1.02 Billion | 464 Million |
| Net Income | 625.77 Million | 408.36 Million | 13.47 Million | 337.94 Million | 154 Million |
| Depreciation & Amortization | 328.22 Million | 332.95 Million | 392.56 Million | 438.27 Million | 408 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 27.84 Million | -19.88 Million | 487.81 Million | 309.65 Million | 865 Million |
| Other non-cash items | 171.46 Million | 193.99 Million | -59.06 Million | 15.91 Million | -963 Million |
| Investing Cash Flow | -552.23 Million | -473.7 Million | 43.33 Million | -131.78 Million | -284 Million |
| Investments in PPE | -564.98 Million | -689.96 Million | -92.67 Million | -376.08 Million | -183 Million |
| Acquisitions | - | - | - | -128.97 Million | - |
| Investment purchases | -11.87 Million | -11.8 Million | -1.76 Million | -101.4 Million | -37.29 Million |
| Sales/Maturities of investments | 29.1 Million | 216.24 Million | 133 Million | 204.64 Million | - |
| Other Investing Activities | -4.47 Million | 11.82 Million | 4.76 Million | 270.03 Million | -101 Million |
| Financing Cash Flow | -443.6 Million | -142.94 Million | -525.52 Million | -563.99 Million | -661 Million |
| Debt repayment | -200.7 Million | -134.3 Million | -236.56 Million | -286.79 Million | -260 Million |
| Dividends payments | -200.24 Million | -200.01 Million | -199.44 Million | -199.89 Million | -212.08 Million |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -1000.00 | -1000.00 | -19 Thousand | 172 Million | -2000.00 |
| Accounts receivables | -607 Million | 139 Million | 264 Million | 184 Million | 800 Million |
| Accounts payables | 674.4 Million | 256.76 Million | 230.75 Million | 88.11 Million | -675.01 Million |
| Inventory | 57.47 Million | -456 Million | -93.51 Million | 981 Thousand | 70 Million |
| Other working capital | 112 Million | 150 Million | 85 Million | 39 Million | -5 Million |
| Cash at beginning of period | 3.93 Billion | 4.02 Billion | 3.25 Billion | 2.91 Billion | 3.41 Billion |
| Cash at end of period | 4.04 Billion | 3.93 Billion | 4.02 Billion | 3.25 Billion | -496 Million |
| Capital Expenditure | -564.98 Million | -689.96 Million | -92.67 Million | -376.08 Million | -183 Million |
| Effect of forex changes on cash | 22.65 Million | 22.48 Million | 57.4 Million | 5.3 Million | -15 Million |
| Net cash flow / Change in cash | 109.89 Million | -93.51 Million | 775.02 Million | 334.93 Million | -3.9 Billion |
| Free Cash Flow | 518.08 Million | -189.31 Million | 1.1 Billion | 649.32 Million | 281 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 104 Million | 57 Million | 625.77 Million | 247 Million | -4 Million | 76 Million |
| Depreciation & Amortization | - | - | 328.22 Million | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 27.84 Million | - | - | - |
| Other non-cash items | -104 Million | -57 Million | 171.46 Million | -247 Million | 4 Million | -76 Million |
| Investing Cash Flow | - | - | -552.23 Million | - | - | - |
| Investments in PPE | - | - | -564.98 Million | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -11.87 Million | - | - | - |
| Sales/Maturities of investments | - | - | 29.1 Million | - | - | - |
| Other Investing Activities | - | - | -4.47 Million | - | - | - |
| Financing Cash Flow | - | - | -443.6 Million | - | - | - |
| Debt repayment | - | - | -200.7 Million | - | - | - |
| Dividends payments | - | - | -200.24 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -1000.00 | - | - | - |
| Accounts receivables | - | - | -607 Million | - | - | - |
| Accounts payables | - | - | 674.4 Million | - | - | - |
| Inventory | - | - | 57.47 Million | - | - | - |
| Other working capital | - | - | 112 Million | - | - | - |
| Cash at beginning of period | - | - | 3.93 Billion | - | - | - |
| Cash at end of period | - | - | 4.04 Billion | - | - | - |
| Capital Expenditure | - | - | -564.98 Million | - | - | - |
| Effect of forex changes on cash | - | - | 22.65 Million | - | - | - |
| Net cash flow / Change in cash | - | - | 109.89 Million | - | - | - |
| Free Cash Flow | - | - | 518.08 Million | - | - | - |
INL
MUKKA
BSGM
000507
000935
002316